EudraVigilance,<\/a>\u00a0which also tracks reports of injuries and deaths following the experimental COVID-19 \u201cvaccines.\u201d<\/em><\/p>\nA subscriber from Europe recently emailed us and reminded us that this database maintained at EudraVigilance is only for countries in Europe who are part of the European Union (EU), which comprises 27 countries.<\/p>\n
The total number of countries in Europe is much higher, almost twice as many, numbering around 50, . . .<\/p>\n
So as high as these numbers are, they do NOT reflect all of Europe. The actual number in Europe who are reported dead or injured due to COVID-19 shots would be much higher than what we are reporting here. . . .<\/p>\n
From the total of injuries recorded, half of them (753,657) are\u00a0serious<\/strong>\u00a0injuries.<\/p>\n\u201cSeriousness<\/strong>\u00a0provides information on the suspected undesirable effect; it can be classified as \u2018serious\u2019 if it corresponds to a medical occurrence that results in\u00a0death<\/strong>, is life-threatening, requires inpatient hospitalisation, results in another medically important condition, or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, or is a congenital anomaly\/birth defect.\u201d<\/em><\/p>\n<\/blockquote>\nHe then presents the \u201csummary data through June 19, 2021.\u201d It has to be seen in its entirety to be believed:<\/p>\n
Total reactions<\/strong>\u00a0for the experimental mRNA vaccine\u00a0Tozinameran<\/strong>\u00a0(code\u00a0BNT162b2<\/strong>,Comirnaty<\/strong>) from\u00a0BioNTech<\/strong>\/\u00a0<\/strong>Pfizer:\u00a0<\/strong>7,420 deaths\u00a0<\/strong>and\u00a0560,256\u00a0<\/strong>injuries to 19\/06\/2021<\/p>\n\n- 16,133\u00a0\u00a0 Blood and lymphatic system disorders\u00a0incl. 81 deaths<\/strong><\/li>\n
- 12,637\u00a0\u00a0 Cardiac disorders\u00a0incl. 964 deaths<\/strong><\/li>\n
- 101\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Congenital, familial and genetic disorders\u00a0incl. 6 deaths<\/strong><\/li>\n
- 7000\u00a0\u00a0\u00a0\u00a0\u00a0 Ear and labyrinth disorders\u00a0incl. 4 deaths<\/strong><\/li>\n
- 265\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Endocrine disorders\u00a0incl. 1 death<\/strong><\/li>\n
- 8,122\u00a0\u00a0\u00a0\u00a0 Eye disorders\u00a0incl.<\/strong>\u00a017 deaths<\/strong><\/li>\n
- 51,030\u00a0\u00a0 Gastrointestinal disorders\u00a0incl. 348 deaths<\/strong><\/li>\n
- 155,486 General disorders and administration site conditions\u00a0incl. 2,290 deaths<\/strong><\/li>\n
- 468\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hepatobiliary disorders\u00a0incl. 31 deaths<\/strong><\/li>\n
- 6,110\u00a0\u00a0\u00a0\u00a0 Immune system disorders\u00a0incl. 32 deaths<\/strong><\/li>\n
- 17,549\u00a0\u00a0 Infections and infestations\u00a0incl. 762 deaths<\/strong><\/li>\n
- 6,275\u00a0\u00a0\u00a0\u00a0 Injury, poisoning and procedural complications\u00a0incl. 104 deaths<\/strong><\/li>\n
- 13,249\u00a0\u00a0 Investigations\u00a0incl. 285 deaths<\/strong><\/li>\n
- 4,162\u00a0\u00a0\u00a0\u00a0 Metabolism and nutrition disorders\u00a0incl. 139 deaths<\/strong><\/li>\n
- 79,125\u00a0\u00a0 Musculoskeletal and connective tissue disorders\u00a0incl. 88 deaths<\/strong><\/li>\n
- 325\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neoplasms benign, malignant and unspecified (incl. cysts and polyps)\u00a0incl. 23 deaths<\/strong><\/li>\n
- 100,895 Nervous system disorders\u00a0incl. 780 deaths<\/strong><\/li>\n
- 384\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pregnancy, puerperium and perinatal conditions\u00a0incl. 10 deaths<\/strong><\/li>\n
- 107\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Product issues<\/li>\n
- 9,928\u00a0\u00a0\u00a0\u00a0 Psychiatric disorders\u00a0incl. 105 deaths<\/strong><\/li>\n
- 1,765\u00a0\u00a0\u00a0\u00a0 Renal and urinary disorders\u00a0incl. 115 deaths<\/strong><\/li>\n
- 2,696\u00a0\u00a0\u00a0\u00a0 Reproductive system and breast disorders\u00a0incl. 3 deaths<\/strong><\/li>\n
- 23,689\u00a0\u00a0 Respiratory, thoracic and mediastinal disorders\u00a0incl. 848 deaths<\/strong><\/li>\n
- 26,641\u00a0\u00a0 Skin and subcutaneous tissue disorders\u00a0incl. 66 deaths<\/strong><\/li>\n
- 846\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Social circumstances\u00a0incl. 10 deaths<\/strong><\/li>\n
- 281\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Surgical and medical procedures\u00a0incl. 19 deaths<\/strong><\/li>\n
- 14,987\u00a0\u00a0 Vascular disorders\u00a0incl. 289 deaths<\/strong><\/li>\n<\/ul>\n
Total reactions<\/strong>\u00a0for the experimental mRNA vaccine\u00a0mRNA-1273\u00a0<\/strong>(<\/strong>CX-024414)\u00a0<\/strong>from<\/strong>\u00a0Moderna:\u00a0<\/strong>4,147 death<\/strong>s\u00a0<\/strong>and\u00a0122,643 injuries<\/strong>\u00a0to 19\/06\/2021<\/p>\n\n- 2,239\u00a0\u00a0\u00a0\u00a0 Blood and lymphatic system disorders\u00a0incl. 29 deaths<\/strong><\/li>\n
- 3,315\u00a0\u00a0\u00a0\u00a0 Cardiac disorders\u00a0incl. 446 deaths<\/strong><\/li>\n
- 39\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Congenital, familial and genetic disorders\u00a0incl. 3 deaths<\/strong><\/li>\n
- 1,454\u00a0\u00a0\u00a0\u00a0 Ear and labyrinth disorders<\/li>\n
- 82\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Endocrine disorders\u00a0incl. 1 death<\/strong><\/li>\n
- 1,883\u00a0\u00a0\u00a0\u00a0 Eye disorders\u00a0incl. 7 deaths<\/strong><\/li>\n
- 10,655\u00a0\u00a0 Gastrointestinal disorders\u00a0incl. 142 deaths<\/strong><\/li>\n
- 33,936\u00a0\u00a0 General disorders and administration site conditions\u00a0incl. 1,759 deaths<\/strong><\/li>\n
- 209\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hepatobiliary disorders\u00a0incl. 11 deaths<\/strong><\/li>\n
- 1,117\u00a0\u00a0\u00a0\u00a0 Immune system disorders\u00a0incl. 5 deaths<\/strong><\/li>\n
- 3,835\u00a0\u00a0\u00a0\u00a0 Infections and infestations\u00a0incl. 234 deaths<\/strong><\/li>\n
- 2,480\u00a0\u00a0\u00a0\u00a0 Injury, poisoning and procedural complications\u00a0incl. 77 deaths<\/strong><\/li>\n
- 2,670\u00a0\u00a0\u00a0\u00a0 Investigations\u00a0incl. 89 deaths<\/strong><\/li>\n
- 1,297\u00a0\u00a0\u00a0\u00a0 Metabolism and nutrition disorders\u00a0incl. 85 deaths<\/strong><\/li>\n
- 15,131\u00a0\u00a0 Musculoskeletal and connective tissue disorders\u00a0incl. 77 deaths<\/strong><\/li>\n
- 128\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neoplasms benign, malignant and unspecified (incl. cysts and polyps)\u00a0incl. 15 deaths<\/strong><\/li>\n
- 21,684\u00a0\u00a0 Nervous system disorders\u00a0incl. 424 deaths<\/strong><\/li>\n
- 255\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pregnancy, puerperium and perinatal conditions\u00a0incl. 2 death<\/strong><\/li>\n
- 20\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Product issues<\/li>\n
- 2,437\u00a0\u00a0\u00a0\u00a0 Psychiatric disorders\u00a0incl. 69 deaths<\/strong><\/li>\n
- 807\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Renal and urinary disorders\u00a0incl. 52 deaths<\/strong><\/li>\n
- 459\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Reproductive system and breast disorders\u00a0incl. 1 death<\/strong><\/li>\n
- 5,640\u00a0\u00a0\u00a0\u00a0 Respiratory, thoracic and mediastinal disorders\u00a0incl. 399 deaths<\/strong><\/li>\n
- 6,538\u00a0\u00a0\u00a0\u00a0 Skin and subcutaneous tissue disorders\u00a0incl. 28 deaths<\/strong><\/li>\n
- 504\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Social circumstances\u00a0incl. 13 deaths<\/strong><\/li>\n
- 397\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Surgical and medical procedures\u00a0incl. 38 deaths<\/strong><\/li>\n
- 3,432\u00a0\u00a0\u00a0\u00a0 Vascular disorders\u00a0incl. 141 deaths<\/strong><\/li>\n<\/ul>\n
Total reactions<\/strong>\u00a0for the experimental\u00a0vaccine\u00a0<\/strong>AZD1222<\/strong>\/VAXZEVRIA\u00a0<\/strong>(CHADOX1 NCOV-19)<\/strong>\u00a0from\u00a0<\/strong>Oxford<\/strong>\/<\/strong>AstraZeneca<\/strong>:\u00a03,364 death<\/strong>s\u00a0<\/strong>and\u00a0793,036 injuries<\/strong>\u00a0to 19\/06\/2021<\/p>\n\n- 9,136\u00a0\u00a0\u00a0\u00a0 Blood and lymphatic system disorders\u00a0incl. 132 deaths<\/strong><\/li>\n
- 12,135\u00a0\u00a0 Cardiac disorders\u00a0incl. 396 deaths<\/strong><\/li>\n
- 95\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Congenital, familial and genetic disorders\u00a0incl. 2 deaths<\/strong><\/li>\n
- 8,797\u00a0\u00a0\u00a0\u00a0 Ear and labyrinth disorders<\/li>\n
- 309\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Endocrine disorders\u00a0incl. 2 deaths<\/strong><\/li>\n
- 13,459\u00a0\u00a0 Eye disorders\u00a0incl. 12 deaths<\/strong><\/li>\n
- 81,806\u00a0\u00a0 Gastrointestinal disorders\u00a0incl. 161 deaths<\/strong><\/li>\n
- 212,663 General disorders and administration site conditions\u00a0incl. 891 deaths<\/strong><\/li>\n
- 525\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hepatobiliary disorders\u00a0incl. 25 deaths<\/strong><\/li>\n
- 3,085\u00a0\u00a0\u00a0\u00a0 Immune system disorders\u00a0incl. 11 deaths<\/strong><\/li>\n
- 17,791\u00a0\u00a0 Infections and infestations\u00a0incl. 217 deaths<\/strong><\/li>\n
- 7,854\u00a0\u00a0\u00a0\u00a0 Injury, poisoning and procedural complications\u00a0incl. 77 deaths<\/strong><\/li>\n
- 16,731\u00a0\u00a0 Investigations\u00a0incl. 79 deaths<\/strong><\/li>\n
- 9,765\u00a0\u00a0\u00a0\u00a0 Metabolism and nutrition disorders\u00a0incl. 50 deaths<\/strong><\/li>\n
- 123,637 Musculoskeletal and connective tissue disorders\u00a0incl. 45 deaths<\/strong><\/li>\n
- 332\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neoplasms benign, malignant and unspecified (incl. cysts and polyps)\u00a0incl. 8 deaths<\/strong><\/li>\n
- 169,286 Nervous system disorders\u00a0incl. 532 deaths<\/strong><\/li>\n
- 223\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pregnancy, puerperium and perinatal conditions\u00a0incl. 4 deaths<\/strong><\/li>\n
- 103\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Product issues<\/li>\n
- 14,931\u00a0\u00a0 Psychiatric disorders\u00a0incl. 27 deaths<\/strong><\/li>\n
- 2,809\u00a0\u00a0\u00a0\u00a0 Renal and urinary disorders\u00a0incl. 29 deaths<\/strong><\/li>\n
- 5,967\u00a0\u00a0\u00a0\u00a0 Reproductive system and breast disorders<\/li>\n
- 26,631\u00a0\u00a0 Respiratory, thoracic and mediastinal disorders\u00a0incl. 387 deaths<\/strong><\/li>\n
- 36,457\u00a0\u00a0 Skin and subcutaneous tissue disorders\u00a0incl. 22 deaths<\/strong><\/li>\n
- 772\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Social circumstances\u00a0incl. 4 deaths<\/strong><\/li>\n
- 671\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Surgical and medical procedures\u00a0incl. 16 deaths<\/strong><\/li>\n
- 17,066\u00a0\u00a0 Vascular disorders\u00a0incl. 235 deaths<\/strong><\/li>\n<\/ul>\n
Total reactions<\/strong>\u00a0for the experimental\u00a0COVID-19 vaccine JANSSEN (AD26.COV2.S)\u00a0from\u00a0<\/strong>Johnson & Johnson<\/strong>:\u00a0541 deaths\u00a0<\/strong>and\u00a033, 331 injuries<\/strong>\u00a0to 19\/06\/2021<\/p>\n\n- 306\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Blood and lymphatic system disorders\u00a0incl. 16 deaths<\/strong><\/li>\n
- 496\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Cardiac disorders\u00a0incl. 56 deaths<\/strong><\/li>\n
- 14\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Congenital, familial and genetic disorders<\/li>\n
- 177\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Ear and labyrinth disorders<\/li>\n
- 8\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Endocrine disorders\u00a0incl. 1 death<\/strong><\/li>\n
- 383\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Eye disorders\u00a0incl. 3 deaths<\/strong><\/li>\n
- 3,086\u00a0\u00a0\u00a0\u00a0 Gastrointestinal disorders\u00a0incl. 23 deaths<\/strong><\/li>\n
- 8,761\u00a0\u00a0\u00a0\u00a0 General disorders and administration site conditions\u00a0incl. 137 deaths<\/strong><\/li>\n
- 52\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Hepatobiliary disorders\u00a0incl. 4 deaths<\/strong><\/li>\n
- 85\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Immune system disorders<\/li>\n
- 392\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Infections and infestations\u00a0incl. 13 deaths<\/strong><\/li>\n
- 320\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Injury, poisoning and procedural complications\u00a0incl. 8 deaths<\/strong><\/li>\n
- 2,003\u00a0\u00a0\u00a0\u00a0 Investigations\u00a0incl. 37 deaths<\/strong><\/li>\n
- 184\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Metabolism and nutrition disorders\u00a0incl. 10 deaths<\/strong><\/li>\n
- 5,718\u00a0\u00a0\u00a0\u00a0 Musculoskeletal and connective tissue disorders\u00a0incl. 17 deaths<\/strong><\/li>\n
- 16\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Neoplasms benign, malignant and unspecified (incl. cysts and polyps)<\/li>\n
- 7,093\u00a0\u00a0\u00a0\u00a0 Nervous system disorders\u00a0incl. 68 deaths<\/strong><\/li>\n
- 9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Pregnancy, puerperium and perinatal conditions\u00a0incl. 1 death<\/strong><\/li>\n
- 9\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Product issues<\/li>\n
- 355\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Psychiatric disorders\u00a0incl. 5 deaths<\/strong><\/li>\n
- 119\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Renal and urinary disorders\u00a0incl. 8 deaths<\/strong><\/li>\n
- 114\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Reproductive system and breast disorders<\/li>\n
- 1,130\u00a0\u00a0\u00a0\u00a0 Respiratory, thoracic and mediastinal disorders\u00a0incl. 43 deaths<\/strong><\/li>\n
- 804\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Skin and subcutaneous tissue disorders\u00a0incl. 2 deaths<\/strong><\/li>\n
- 72\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Social circumstances\u00a0incl. 3 deaths<\/strong><\/li>\n
- 336\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Surgical and medical procedures\u00a0incl. 26 deaths<\/strong><\/li>\n
- 1,289\u00a0\u00a0\u00a0\u00a0 Vascular disorders\u00a0incl. 60 deaths<\/strong><\/li>\n<\/ul>\n
See the related materials:<\/p>\n
WHAT?! Vaccinated = Higher Overall Death Rate in UK (Also, Two-Thirds of Deaths in the UK from the Delta Variant of COVID-19 Were Among Vaccinated People)<\/a> [Dave Armstrong, 11-4-21]<\/p>\n
![\"\"](\"https:\/\/wp-media.patheos.com\/blogs\/sites\/572\/2021\/11\/GraphUpward2.png\")
<\/a><\/p>\n